Skip to main content

Advertisement

Table 1 Baseline characteristics by treatment group at randomization

From: On-demand intermittent beclomethasone is effective for mild asthma in Brazil

  Intermittent (n = 94) Continuous (n = 94) p value
Age in years, mean (SD) 10.6 (2.8) 9.9 (2.7) 0.09
Sex (boys) 55 (58.5) 50 (53.2) 0.55
Height (cm) 145.1 (15.3) 142.1(14.1) 0.12
Family monthly income (Brazilian minimum wage) 2.4 (1.6) 2.3 (1.5) 0.55
Mother’s schooling (literate) 93 (99.0) 92 (97.9) 0.75
Ethnic group (white) 84 (89.3) 52 (55.3) 0.20
Number of siblings (up to three) 68 (72.3) 73 (77.6) 0.84
Parental history of allergic rhinitis (yes) 60 (63.8) 64 (68.0) 0.87
Parental history of asthma 54 (57.4) 52 (55.3) 0.81
Exposure to mould (yes) 38 (40.4) 38 (40.4) 0.88
Exposure to house dust mite (yes) 72 (76.6) 72 (76.6) 0.96
ACT/cACT score, mean (SD) 21.9 (3.0) 22.0 (2.7) 0.80
Previous ICS treatment (250–500 μg of beclomethasone or equivalent) 87 (92.5) 91 (96.8) 0.33
Allergic rhinitis/continuous intranasal budesonide (yes) 36 (38.2) 29 (30.8) 0.28
Allergic rhinitis scoring (points)a 6.6 (3.7) 6.1 (4.1) 0.44
Pre-bronchodilator FEV1 (%), mean (SD) 88.2 (12.1) 89.8 (12.0) 0.39
Bronchodilator response (%), mean (SD) 7.7 (8.5) 7.2 (7.6) 0.95
  1. Data are proportions (%) or means (SD) unless stated otherwise; one Brazilian minimum wage corresponded approximately to US$ 250.00 during the study period
  2. ACT/cACT asthma control test/childhood-asthma control test, FEV 1 forced expiratory volume in 1 s
  3. aDescribed by Wilson et al. [9]